The HIV+Hepatitis Policy Institute thanks you for the opportunity to comment on the U.S. Preventive Services Task Force (USPSTF) Draft Recommendation Statement: Prevention of Human Immunodeficiency Virus (HIV) Infection: Preexposure Prophylaxis (PrEP). On October 1, 2022, HIV+Hep submitted a request, supported by 62 additional organizations, asking the USPSTF to update the existing PrEP recommendation to include long-acting injectable PrEP. We commend you for conducting and completing this timely and thorough update.
Comments in support of hepatitis B universal adult vaccination
HIV+Hep strongly supports a recommendation for universal hepatitis B vaccination for all adults. The hepatitis B vaccine is safe and effective, with over 1 billion doses administered worldwide and is estimated to have prevented over 310 million infections worldwide between 1990 and 2020. Despite highly effective vaccines, up to 2.4 million people in the United States may be living with chronic hepatitis B, and there are up to 80,000 new cases of hepatitis B each year. With the proper guidance and resources, each new infection is preventable.
Comments recommending PrEP in STI counseling and Well-Woman Preventive Visits
The HIV+Hepatitis Policy Institute submitted the following comments to the Women’s Preventive Services Institute recommending that HIV preexposure prophylaxis (PrEP) be included for all women at risk of HIV as part of sexually transmitted infection counseling and as part of the Well-Woman Preventive visits, as they update HRSA’s recommended preventive services for women.
Comments on draft sexually transmitted infections national strategic plan 2021-2025
Thank you for the opportunity to provide comments on the draft Sexually Transmitted Infections National Strategic Plan 2021-2025 (STI Plan). The HIV+Hepatitis Policy Institute is a leading HIV…